Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...

Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for patients who have a prescription for the medication but no insurance coverage ...

Novo Nordisk has introduced its weight-loss drug, Wegovy, in India. This launch follows Eli Lilly's entry into the market.

Wegovy is the first drug in India approved for both weight management and risk reduction of major adverse cardiovascular events in individuals with established heart disease.

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, though it is exploring oral semaglutide for obesity.

Currently, two criteria must be met to qualify for the prescription. Firstly, a BMI of 40 or over is required, however, if ...

Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle ...

Irrespective of what we don’t know, the advent of Mounjaro as a substitute for self-control and willpower is entirely in keeping with our labour-saving, quick-fix culture. Why worry when we now have ...

New once-a-month drug could treat diabetes and obesity, scientists say - Researchers say experimental drug’s less frequent ...

Mounjaro has been accessible in specialist NHS weight loss clinics since March. Another weight loss medication, Wegovy, also ...

Weight loss surgery has long been an effective treatment for the more than 40 percent of American adults struggling with obesity.

While both drugs belong to the GLP-1 receptor agonist class, Mounjaro has a dual mechanism (GIP and GLP-1), which clinical ...